What is CNFRZ's earnings per share (EPS)?

CNFRZ (CNFRZ) reported diluted earnings per share of -$1.51 for fiscal year 2025. This represents a -178.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CNFRZ Financials

CNFRZ

Trailing 12 months to March 31, 2026

Revenue $39.0M -39.6% YoY

Net Income -$16.3M -165.9% YoY

EPS (Diluted) -$1.51 FY2025 annual

Operating Cash Flow -$36.9M +34.2% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 13, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CNFRZ SEC filings page.

CNFRZ (CNFRZ) reported $39.0M in revenue over the twelve months to Mar 31, 2026, down 39.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CNFRZ FY2025 2026-08-30

Operating losses are consuming cash while shrinking equity makes financing dependence the dominant business mechanic.

FY2024’s accounting profit of $24.3M coincided with operating cash flow of -$32.7M, so reported earnings did not represent cash generated by operations. The mismatch persisted in FY2025, when operating cash flow of -$43.9M was more than twice the net loss of $18.4M, pointing to substantial cash demands beyond the reported loss itself.

Equity fell from $21.5M in FY2024 to $9.0M in FY2025, leaving a much thinner balance-sheet cushion. Debt-to-equity rose from 0.6x to 1.4x over the same period, so the remaining equity supports a larger relative burden of financing claims.

The operating margin deteriorated from -33.7% in FY2023 to -59.8% in FY2025, indicating that shrinking scale has not been matched by cost reduction. FY2025 financing cash flow of $15.5M offset only part of the operating cash outflow, reinforcing that operations were not self-funding.

Financial Health Signals

Financial health score not available

CNFRZ does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

1/7

CNFRZ passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). No profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

CNFRZ reported a net loss of $18.4M while operations used $43.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

CNFRZ reported an operating loss of $25.9M against $3.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$11.5M

YoY-27.3%

QoQ+150.2%

5Y CAGR-15.2%

10Y CAGR-5.8%

CNFRZ generated $11.5M in revenue in Q1 2026. This represents a decrease of 27.3% from the same quarter a year earlier. Against the prior quarter it is up 150.2%.

Net Income

$2.6M

YoY+402.3%

QoQ+115.4%

CNFRZ reported $2.6M in net income in Q1 2026. This represents an increase of 402.3% from the same quarter a year earlier. Against the prior quarter it is up 115.4%.

EPS (Diluted)

$0.15

CNFRZ earned $0.15 per diluted share (EPS) in Q1 2026.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt

$25.5M

YoY+147.7%

QoQ-6.9%

5Y CAGR+41.9%

10Y CAGR+4.9%

CNFRZ held $25.5M in cash against $12.3M in long-term debt as of Q1 2026.

Shares Outstanding

26M

5Y CAGR+22.1%

10Y CAGR+13.1%

CNFRZ had 26M shares outstanding in Q1 2026.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Operating Margin

-9.2%

YoY+18.7pp

5Y change+17.7pp

10Y change+2.7pp

CNFRZ's operating margin was -9.2% in Q1 2026, reflecting core business profitability. This is up 18.7 percentage points from the same quarter a year earlier.

Net Margin

22.7%

YoY+19.4pp

5Y change+40.3pp

10Y change+32.4pp

CNFRZ's net profit margin was 22.7% in Q1 2026, showing the share of revenue converted to profit. This is up 19.4 percentage points from the same quarter a year earlier.

Return on Equity

10.4%

YoY+8.4pp

QoQ+200.5pp

CNFRZ's ROE was 10.4% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 8.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 200.5 percentage points.

Gross Margin

Not reported for Q1 2026.

Capital Allocation

None of these metrics is reported for Q1 2026.

CNFRZ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNFRZ quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Revenue	$39.0M	$43.3M-35.6%	$67.3M-25.7%	$90.5M-13.7%	$104.9M-9.5%	$116.0M+12.1%	$103.5M+7.8%	$96.0M-2.9%	$98.9M+2.1%	$96.8M+3.1%	$93.9M+32.7%	$70.7M+16.1%	$60.9M+82.0%	$33.5M
Operating Income	-$22.5M	-$25.9M+30.6%	-$37.3M-22.4%	-$30.5M-7.5%	-$28.3M-112.2%	-$13.3M-47.0%	-$9.1M+17.7%	-$11.0M-6.8%	-$10.3M+57.3%	-$24.2M-117.7%	-$11.1M	N/A	N/A	N/A
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$10.0M+58.3%	-$23.9M-122.4%	-$10.7M	N/A	N/A	N/A
Interest Expense	$4.6M	$3.2M-34.8%	$4.9M+52.3%	$3.2M+7.9%	$3.0M+4.2%	$2.9M-2.5%	$2.9M+1.5%	$2.9M+9.0%	$2.6M+94.1%	$1.4M+110.5%	$647K-15.9%	$769K+31.7%	$584K+7.9%	$541K
Income Tax	$103K	$141K+107.7%	-$1.8M-421.2%	-$353K+96.3%	-$9.4M-4638.9%	$208K+3366.7%	$6K+100.7%	-$913K-1855.8%	$52K+111.6%	-$447K-480.5%	-$77K-260.4%	$48K+117.1%	-$281K-9466.7%	$3K
Net Income	-$16.3M	-$18.4M-175.7%	$24.3M+193.9%	-$25.9M-142.7%	-$10.7M-876.3%	-$1.1M-283.9%	$595K+107.6%	-$7.8M+15.2%	-$9.2M+57.2%	-$21.5M-155.3%	-$8.4M-13282.8%	$64K+100.9%	-$6.9M-2087.1%	$349K
EPS (Basic)	N/A	-$1.51-178.2%	$1.93+191.0%	-$2.12-112.0%	-$1.00-809.1%	-$0.11-283.3%	$0.06	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	—	-$1.51-178.2%	$1.93+191.0%	-$2.12-112.0%	-$1.00-809.1%	-$0.11-283.3%	$0.06	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	12M0.0%	12M0.0%	12M+14.3%	11M+10.3%	10M+0.7%	10M	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$11.5M-27.3%	$4.6M-68.7%	$6.7M-58.3%	$16.1M-9.9%	$15.9M-14.8%	$14.7M-5.5%	$16.0M-37.0%	$17.9M-28.2%
Operating Income	-$1.1M+76.0%	-$14.9M+42.9%	-$2.9M+60.3%	-$3.6M+16.2%	-$4.4M-997.2%	-$26.1M-32.1%	-$7.3M-37.9%	-$4.4M+17.3%
Interest Expense	$2.0M+265.2%	$906K+5.0%	$874K-61.6%	$864K-0.5%	$541K-38.3%	$863K+2.1%	$2.3M+166.1%	$868K+5.9%
Income Tax	-$38K	$141K+1181.8%	$0+100.0%	$0+100.0%	$0+100.0%	$11K-89.4%	-$1.4M-199.1%	-$333K
Net Income	$2.6M+402.3%	-$17.0M+30.6%	-$4.0M-107.5%	$2.1M+151.9%	$522K+605.4%	-$24.6M-26.1%	$52.8M+2050.8%	-$4.0M+16.6%
EPS (Basic)	$0.15+275.0%	N/A	-$0.32-107.4%	$0.17+153.1%	$0.04+300.0%	N/A	$4.32+2063.6%	-$0.32+17.9%
EPS (Diluted)	$0.15	N/A	-$0.32-107.4%	$0.17+153.1%	$0.04	N/A	$4.32+2063.6%	-$0.32+17.9%
Diluted Shares (Avg)	17M	N/A	12M0.0%	12M0.0%	12M	N/A	12M0.0%	12M0.0%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA.

CNFRZ Balance Sheet

CNFRZ quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Total Assets	$239.3M-15.0%	$281.7M-10.8%	$315.6M+1.0%	$312.4M+7.6%	$290.4M+11.0%	$261.6M+5.8%	$247.3M+6.2%	$232.8M-2.6%	$239.0M+17.3%	$203.7M+14.5%	$177.9M+8.7%	$163.7M	N/A
Cash & Equivalents	$27.4M-1.1%	$27.7M+159.3%	$10.7M-62.0%	$28.0M+182.8%	$9.9M+21.0%	$8.2M+9.8%	$7.5M-30.8%	$10.8M-9.1%	$11.9M-5.0%	$12.5M-1.7%	$12.7M-31.3%	$18.5M+63.7%	$11.3M
Short-Term Investments	$24.7M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.1M	N/A
Total Liabilities	$230.3M-11.5%	$260.1M-16.8%	$312.7M+6.6%	$293.4M+17.4%	$249.9M+15.1%	$217.2M+6.2%	$204.5M+7.3%	$190.6M+2.4%	$186.2M+37.0%	$135.9M+35.0%	$100.7M-11.3%	$113.5M	N/A
Long-Term Debt	$12.2M+2.1%	$11.9M-52.4%	$25.1M-26.0%	$33.9M+0.9%	$33.6M-18.1%	$41.0M+14.4%	$35.8M+6.9%	$33.5M+15.4%	$29.0M+63.5%	$17.8M+39.2%	$12.8M-53.7%	$27.6M	N/A
Total Equity	$9.0M-58.3%	$21.5M+645.1%	$2.9M-84.8%	$18.9M-53.2%	$40.5M-8.8%	$44.4M+4.0%	$42.7M+1.3%	$42.2M-20.2%	$52.8M-22.1%	$67.8M-12.3%	$77.3M+74.9%	$44.2M+107.9%	$21.3M
Retained Earnings	-$81.6M-29.2%	-$63.2M+27.1%	-$86.7M-42.7%	-$60.8M-21.3%	-$50.1M-2.2%	-$49.0M+1.2%	-$49.6M-18.7%	-$41.8M-26.5%	-$33.0M-187.8%	-$11.5M-278.4%	-$3.0M+2.1%	-$3.1M	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$236.6M-14.6%	$239.3M-15.0%	$285.0M-5.0%	$283.3M-3.3%	$277.1M-8.0%	$281.7M-10.8%	$299.9M+2.2%	$292.9M-1.2%
Cash & Equivalents	$25.5M+147.7%	$27.4M-1.1%	$7.4M-77.1%	$22.0M+126.4%	$10.3M-40.6%	$27.7M+159.3%	$32.4M+125.5%	$9.7M-48.3%
Total Liabilities	$211.4M-15.9%	$230.3M-11.5%	$259.7M+3.5%	$255.1M-13.3%	$251.5M-15.8%	$260.1M-16.8%	$250.8M-11.0%	$294.1M+5.2%
Long-Term Debt	$12.3M+2.1%	$12.2M+2.1%	$12.1M-26.4%	$12.1M-51.4%	$12.0M-51.9%	$11.9M-52.4%	$16.5M-34.8%	$24.8M-27.0%
Total Equity	$25.2M-1.5%	$9.0M-58.3%	$25.3M-48.4%	$28.2M+2521.3%	$25.6M+899.8%	$21.5M+645.1%	$49.1M+316.0%	-$1.2M-106.9%
Retained Earnings	-$79.0M-26.1%	-$81.6M-29.2%	-$64.5M-70.9%	-$60.6M+33.1%	-$62.6M+27.7%	-$63.2M+27.1%	-$37.8M+43.8%	-$90.6M-40.4%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.

CNFRZ Cash Flow Statement

CNFRZ quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Operating Cash Flow	-$36.9M	-$43.9M-34.3%	-$32.7M-144.0%	-$13.4M+66.9%	-$40.5M-855.8%	$5.4M+79.6%	$3.0M-80.6%	$15.4M+190.3%	-$17.0M-287.1%	$9.1M+47.4%	$6.2M+296.6%	-$3.1M-149.7%	$6.3M+148.0%	$2.5M
Depreciation & Amortization	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$386K+3.8%	$372K-7.2%	$401K+0.8%	$398K	N/A	N/A
Stock-Based Compensation	N/A	$56K-28.2%	$78K-58.9%	$190K-10.0%	$211K-3.2%	$218K-69.1%	$706K-26.4%	$959K-1.1%	$970K+8.4%	$895K+4.6%	$856K+182.5%	$303K	$0	$0
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	$78K+27.9%	$61K-29.1%	$86K+561.5%	$13K-93.3%	$195K+16.8%	$167K-62.4%	$444K+56.9%	$283K
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	$2.9M-81.0%	$15.3M+189.5%	-$17.1M-288.3%	$9.1M+52.0%	$6.0M+280.8%	-$3.3M-156.4%	$5.9M+159.5%	$2.3M
Investing Cash Flow	N/A	N/A	N/A	-$272K-100.5%	$56.5M+4003.3%	$1.4M+118.8%	-$7.3M+70.7%	-$25.0M-304.7%	$12.2M+147.1%	-$26.0M-141.4%	-$10.8M+29.7%	-$15.3M+67.9%	-$47.7M	N/A
Financing Cash Flow	$14.2M	$15.5M+173.5%	-$21.1M-549.6%	-$3.2M-255.1%	$2.1M+141.8%	-$5.0M-198.6%	$5.1M-19.6%	$6.3M+70.5%	$3.7M-77.2%	$16.2M+271.2%	$4.4M-65.4%	$12.6M-74.0%	$48.6M	N/A
Dividends Paid	$0	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	$12K-66.7%	$36K-94.7%	$676K+6.3%	$636K	$0-100.0%	$625K	$0	$0	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	-$8.3M+45.6%	-$25.2M-25.9%	-$681K+93.7%	-$2.8M+72.8%	-$15.3M-286.7%	-$20.0M-57.9%	-$10.7M-1593.9%	-$10.1M-321.5%
Stock-Based Compensation	$13K-13.3%	N/A	N/A	N/A	$15K-53.1%	N/A	N/A	N/A
Investing Cash Flow	$168K+101.7%	N/A	-$13.9M-128.2%	$14.4M+394.8%	-$9.6M-517.0%	N/A	$49.2M+1200.8%	$2.9M+139.7%
Financing Cash Flow	$6.2M-16.7%	$8.0M+277.8%	$0+100.0%	$0+100.0%	$7.5M+1860.6%	-$4.5M-179.5%	-$15.8M-76.9%	-$408K-13500.0%
Dividends Paid	$0	$0	$0	$0+100.0%	$0-100.0%	$0	$0	-$176K

Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Share Buybacks.

CNFRZ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNFRZ quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Operating Margin	-59.8%-4.4pp	-55.4%-21.8pp	-33.7%-6.6pp	-27.0%-15.5pp	-11.5%-2.7pp	-8.8%+2.7pp	-11.5%-1.1pp	-10.4%+14.6pp	-25.0%-13.2pp	-11.9%	N/A	N/A	N/A
Net Margin	-42.6%-78.8pp	36.2%+64.8pp	-28.6%-18.5pp	-10.2%-9.2pp	-0.9%-1.5pp	0.6%+8.7pp	-8.2%+1.2pp	-9.3%+12.9pp	-22.3%-13.3pp	-9.0%-9.1pp	0.1%+11.5pp	-11.4%-12.4pp	1.0%
Return on Equity	-205.6%-318.8pp	113.1%+1010.4pp	-897.3%-840.9pp	-56.4%-53.7pp	-2.7%-4.0pp	1.3%+19.7pp	-18.3%+3.6pp	-21.9%+18.9pp	-40.8%-28.3pp	-12.4%-12.5pp	0.1%+15.8pp	-15.7%-17.3pp	1.6%
Return on Assets	-7.7%-16.4pp	8.6%+16.9pp	-8.2%-4.8pp	-3.4%-3.0pp	-0.4%-0.6pp	0.2%+3.4pp	-3.2%+0.8pp	-4.0%+5.0pp	-9.0%-4.9pp	-4.1%-4.2pp	0.0%+4.3pp	-4.2%	N/A
Debt-to-Equity	1.36+0.8x	0.55-8.1x	8.67+6.9x	1.79+1.0x	0.83-0.1x	0.92+0.1x	0.840.0x	0.79+0.2x	0.55+0.3x	0.26+0.1x	0.17-0.5x	0.62	N/A
Asset Turnover	0.18-0.1x	0.240.0x	0.290.0x	0.34-0.1x	0.400.0x	0.400.0x	0.390.0x	0.420.0x	0.41-0.1x	0.46+0.1x	0.400.0x	0.37	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	2.8%-13.1pp	15.9%+33.2pp	-17.3%-26.7pp	9.4%+3.0pp	6.4%+11.0pp	-4.7%-14.3pp	9.6%+2.9pp	6.8%

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Margin	-9.2%+18.7pp	-322.7%	-43.6%+2.1pp	-22.6%+1.7pp	-27.9%-30.6pp	-177.1%	-45.8%-24.9pp	-24.3%-3.2pp
Net Margin	22.7%+19.4pp	-369.2%	-59.4%	12.7%+34.8pp	3.3%+2.9pp	-166.8%	329.6%	-22.1%-3.0pp
Return on Equity	10.4%+8.4pp	-190.1%-75.9pp	-15.7%-123.3pp	7.3%	2.0%-0.8pp	-114.1%+560.1pp	107.6%+130.6pp	N/A
Return on Assets	1.1%+0.9pp	-7.1%+1.6pp	-1.4%-19.0pp	0.7%+2.1pp	0.2%+0.2pp	-8.7%-2.6pp	17.6%+18.5pp	-1.4%+0.3pp
Debt-to-Equity	0.490.0x	1.36+0.8x	0.48+0.1x	0.43	0.47-9.3x	0.55-8.1x	0.34-1.8x	N/A
Asset Turnover	0.050.0x	0.020.0x	0.020.0x	0.060.0x	0.060.0x	0.050.0x	0.050.0x	0.060.0x

Not reported in any period shown, so not listed: Gross Margin, Current Ratio, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Where CNFRZ Ranks

Frequently Asked Questions

What is CNFRZ's annual revenue?

CNFRZ (CNFRZ) reported $43.3M in total revenue for fiscal year 2025. This represents a -35.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CNFRZ's revenue growing?

CNFRZ (CNFRZ) revenue declined by 35.6% year-over-year, from $67.3M to $43.3M in fiscal year 2025.

Is CNFRZ profitable?

No, CNFRZ (CNFRZ) reported a net income of -$18.4M in fiscal year 2025, with a net profit margin of -42.6%.

How much debt does CNFRZ have?

As of fiscal year 2025, CNFRZ (CNFRZ) had $27.4M in cash and equivalents against $12.2M in long-term debt.

What is CNFRZ's operating margin?

CNFRZ (CNFRZ) had an operating margin of -59.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CNFRZ's net profit margin?

CNFRZ (CNFRZ) had a net profit margin of -42.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CNFRZ's return on equity (ROE)?

CNFRZ (CNFRZ) has a return on equity of -205.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CNFRZ's operating cash flow?

CNFRZ (CNFRZ) recorded an outflow of $43.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are CNFRZ's total assets?

CNFRZ (CNFRZ) had $239.3M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does CNFRZ have outstanding?

CNFRZ (CNFRZ) had 12M shares outstanding as of fiscal year 2025.

What is CNFRZ's debt-to-equity ratio?

CNFRZ (CNFRZ) had a debt-to-equity ratio of 1.36 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CNFRZ's return on assets (ROA)?

CNFRZ (CNFRZ) had a return on assets of -7.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CNFRZ's Piotroski F-Score?

CNFRZ (CNFRZ) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CNFRZ's earnings high quality?

CNFRZ (CNFRZ) reported a net loss of $18.4M while operations used $43.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CNFRZ cover its interest payments?

CNFRZ (CNFRZ) reported an operating loss of $25.9M against $3.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.